secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001387131-22-012368
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals increases authorized common shares from 150M to 1B
------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common stock from 150,000,000 to 1,000,000,000 shares.
- Vote totals: 242,748,061 for, 46,849,004 against, 746,889 abstentions.
- Series A preferred stock (10 votes/share) and Series B (2,500 votes/share) cast in favor or mirrored common vote.
- Special meeting held December 13, 2022; record date October 28, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/0001387131-22-012368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713122012368/tnxp-8k_121322.htm
  HTML page:      https://secwatch.observer/filing/0001387131-22-012368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer